According to a new report published by Leafly this morning, the CBD market is plagued by inaccuracies, especially when it comes to the amount of this chemical compound present in products sold across the U.S., versus what labels say.

“We are in a Goldilocks and the Three Bears moment when it comes to CBD and the CBD market. Some products have way too little CBD; some are delivering way too much; and some are delivering just the right amount. That’s what we found in our testing program,” Bruce Barcott, author of the report and senior editor at Leafly, said during an exclusive conversation.

The Study

The findings mentioned above derived from the independent testing of 47 popular CBD products; the tests were conducted by Leafly and Confidence Analytics, a Washington state-licensed cannabis lab. What they did was Google terms like “best CBD products” and “cheap CBD,” and purchased many of the products that showed up. They also bought some more products at national drugstore chains like Rite Aid and Walgreens, as well as independent grocery stores, convenience stores, gas stations, and even a surf shop.

We are in a Goldilocks and the Three Bears moment when it comes to CBD and the CBD market. Some products have way too little CBD; some are delivering way too much; and some are delivering just the right amount.”

Among the key findings was that of one in three CBD products containing less than 80% of the CBD they claim to deliver.

More at

Full report at https://www.forbes.com/sites/javierhasse/2019/11/19/cbd-product-mislabeling/#11f8fad23420